Dr Reddy's launches Valsartan tablets in US

Our Bureau | | Updated on: Dec 09, 2021
image caption

Pharma major Dr. Reddy’s Laboratories Ltd has launched Valsartan tablets, a therapeutic equivalent generic version of Diovan (valsartan) tablets approved by the US Food and Drug Administration (USFDA), in the American market.

The Diovan brand and generic market had US sales of approximately $150 million for the most recent 12 months ending October 2021, according to IQVIA Health, said a company release.

Also read: After US nod, AstraZeneca moves Indian authorities over long-acting antibody mix

Dr. Reddy’s Valsartan Tablets are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg, and 320 mg tablets in bottle count sizes of 90.

Published on December 09, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you